24501543|t|Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.
24501543|a|Myelofibrosis (MF) is a rare chronic BCR-ABL1 (breakpoint cluster region-Abelson murine leukemia viral oncogene homologue 1)-negative myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, inefficient hematopoiesis, and shortened survival. The clinical manifestations of MF include splenomegaly, consequent to extramedullary hematopoiesis, cytopenias, and an array of potentially debilitating abdominal and constitutional symptoms. Dysregulated Janus kinase (JAK)-signal transducer and activator of transcription signaling underlies secondary disease-associated effects in MF, such as myeloproliferation, bone marrow fibrosis, constitutional symptoms, and cachexia. Common fatal complications of MF include transformation to acute leukemia, thrombohemorrhagic events, organ failure, and infections. Potential complications from hepatosplenomegaly include portal hypertension and variceal bleeding, whereas extramedullary hematopoiesis outside the spleen and liver - depending on the affected organ - may result in intracranial hypertension, spinal cord compression, pulmonary hypertension, pleural effusions, lymphadenopathy, skin lesions, and/or exacerbation of abdominal symptoms. Although allogeneic stem cell transplantation is the only potentially curative therapy, it is suitable for few patients. The JAK1/JAK2 inhibitor ruxolitinib is effective in improving splenomegaly, MF-related symptoms, and quality-of-life measures. Emerging evidence that ruxolitinib may be associated with a survival benefit in intermediate- or high-risk MF suggests the possibility of a disease-modifying effect. Consequently, ruxolitinib could provide a treatment backbone to which other (conventional and novel) therapies may be added for the prevention and effective management of specific MF-associated complications. 
24501543	0	13	Myelofibrosis	Disease	MESH:D055728
24501543	104	117	Myelofibrosis	Disease	MESH:D055728
24501543	119	121	MF	Disease	MESH:D055728
24501543	141	149	BCR-ABL1	Gene	613;25
24501543	238	265	myeloproliferative neoplasm	Disease	MESH:D009369
24501543	295	315	bone marrow fibrosis	Disease	MESH:D055728
24501543	329	342	hematopoiesis	Disease	MESH:C536227
24501543	399	401	MF	Disease	MESH:D055728
24501543	410	422	splenomegaly	Disease	MESH:D013163
24501543	453	466	hematopoiesis	Disease	MESH:C536227
24501543	468	478	cytopenias	Disease	MESH:D006402
24501543	521	558	abdominal and constitutional symptoms	Disease	MESH:D000007
24501543	701	703	MF	Disease	MESH:D055728
24501543	733	753	bone marrow fibrosis	Disease	MESH:D055728
24501543	755	769	constitutional	Disease	MESH:D005878
24501543	784	792	cachexia	Disease	MESH:D002100
24501543	824	826	MF	Disease	MESH:D055728
24501543	853	867	acute leukemia	Disease	MESH:D015470
24501543	869	887	thrombohemorrhagic	Disease	
24501543	896	909	organ failure	Disease	MESH:D009102
24501543	915	925	infections	Disease	MESH:D007239
24501543	956	974	hepatosplenomegaly	Disease	MESH:C535727
24501543	983	1002	portal hypertension	Disease	MESH:D006975
24501543	1007	1024	variceal bleeding	Disease	MESH:D014648
24501543	1049	1062	hematopoiesis	Disease	MESH:C536227
24501543	1142	1167	intracranial hypertension	Disease	MESH:D019586
24501543	1169	1192	spinal cord compression	Disease	MESH:D013117
24501543	1194	1216	pulmonary hypertension	Disease	MESH:D006976
24501543	1218	1235	pleural effusions	Disease	MESH:D010996
24501543	1237	1252	lymphadenopathy	Disease	MESH:D008206
24501543	1254	1266	skin lesions	Disease	MESH:D012871
24501543	1291	1309	abdominal symptoms	Disease	MESH:D000007
24501543	1422	1430	patients	Species	9606
24501543	1436	1440	JAK1	Gene	3716
24501543	1441	1445	JAK2	Gene	3717
24501543	1456	1467	ruxolitinib	Chemical	MESH:C540383
24501543	1494	1506	splenomegaly	Disease	MESH:D013163
24501543	1508	1510	MF	Disease	MESH:D055728
24501543	1582	1593	ruxolitinib	Chemical	MESH:C540383
24501543	1666	1668	MF	Disease	MESH:D055728
24501543	1739	1750	ruxolitinib	Chemical	MESH:C540383
24501543	1905	1907	MF	Disease	MESH:D055728
24501543	Negative_Correlation	MESH:C540383	3717
24501543	Negative_Correlation	MESH:C540383	3716
24501543	Association	MESH:D055728	613
24501543	Negative_Correlation	MESH:C540383	MESH:D055728
24501543	Association	MESH:D055728	25
24501543	Negative_Correlation	MESH:C540383	MESH:D013163

